Picture of Viveve Medical logo

VIVE — Viveve Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Viveve Medical Announced Positive Primary Efficacy Data From Its Three-Arm, Five-Month Stress Urinary Incontinence Feasibility Study

Aug 25 (Reuters) - Viveve Medical Inc  VIVE.O :
    * VIVEVE MEDICAL - ANNOUNCED POSITIVE PRIMARY EFFICACY DATA
FROM
ITS THREE-ARM, FIVE-MONTH STRESS URINARY INCONTINENCE (SUI)
FEASIBILITY STUDY
    * VIVEVE - POSITIVE OUTCOMES FROM IN-VIVO PRECLINICAL STUDY
CONDUCTED TO VALIDATE ITS NEW INERT SHAM TIP FOR USE IN PIVOTAL
PURSUIT TRIAL IN U.S.

Source: (https://bit.ly/2QmDaDh)
Further company coverage:  VIVE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Viveve Medical

See all news